SK hynix President and CEO Kwak Noh-jung stated that the company is carefully considering the selection of a site for an advanced packaging facility in the United States, targeting all states.On Feb. 19, CEO Kwak made these remarks during a meeting with the press following the regular meeting of the
The ownership dispute within the Hanmi Pharmaceutical Group involving the owning family members is scheduled to be resolved at the shareholders’ meeting next month. The conflict persists between the mother-daughter duo -- Chairperson Song Young-sook, who is pushing for integration with the OCI Group
China is dominating the global battery market backed by overwhelming growth in its home market. Stopping China’s rise in the global battery industry has become a big challenge for Korea, which ranks second in the market behind Chinese companies as well as the United States and Europe.Six of the worl
Civic groups in Pohang, North Gyeongsang Province, collectively known as the “POSCO Citizens’ Response Committee,” held an urgent executive committee meeting on Feb. 12 to formally oppose the nomination of former POSCO President Jang In-hwa as the CEO candidate for POSCO Holdings.The Citizens’ Commi
The CEO Candidate Recommendation Committee of POSCO Holdings finally chose former POSCO President Jang In-hwa, a long-time POSCO insider, with rich experience in the steel business.POSCO Holdings held an extraordinary board meeting on Feb. 8 and resolved to select former POSCO President Jang In-hwa
Samsung Biologics has announced a collaboration with LegoChem Biosciences for the development of Antibody-Drug Conjugate (ADC) therapeutics.On Feb.7, Samsung Biologics revealed it had entered into a new Contract Development Organization (CDO) agreement with LegoChem Biosciences (hereinafter referred
SillaJen announced on Jan. 1 that it has applied to the U.S. Food and Drug Administration (FDA) for approval to amend the Investigational New Drug (IND) application for Phase 1 clinical trials of its BAL0891 cancer drug candidate.BAL0891 is a mitotic checkpoint inhibitor (MCI) class anticancer drug
The sale of ECORBIT, which is considered the key element in the normalization of Taeyoung Engineering & Construction, is gaining momentum with the selection of lead managers. UBS and Citigroup Global Markets Securities, two global investment banks (IBs), have been assigned the task.According to sour
The Korea Investment Corporation (KIC) announced on Jan. 29 that it has established its fifth overseas hub, following the opening of offices in New York, London, Singapore, and San Francisco.The new hub is the Mumbai office in India, marking the KIC’s first overseas presence in an emerging market. T
The Ministry of SMEs and Startups (MSS) is actively moving forward with the designation of new global innovation districts this year. Simultaneously, it is focusing its efforts on strengthening global collaboration programs to foster the venture ecosystem. The ministry plans to strengthen support fo
Following the election of an anti-China candidate in the Taiwanese presidential election, the geopolitical risks associated with Taiwan, a central player in the global semiconductor supply chain, have elevated the roles of Southeast Asian countries like Malaysia, Singapore, and Vietnam as new global
Samsung Electronics and SK hynix will build the world’s largest and best semiconductor mega cluster in the southern part of Gyeonggi Province with a total investment of 622 trillion won. The Korean government will support this project by creating infrastructure and an investment environment, strengt
JW Pharmaceutical announced on Jan. 15 that it has received approval from the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for a phase 3 clinical trial plan, or investigational new drug (IND), of its gout treatment drug Epaminurad (code name URC102).The Phase 3 clinical trial for Epami
Amid police investigations into allegations of illegal expenditures on a local board meeting in Canada by POSCO Holdings, the holding company of POSCO Group, new suspicions have emerged regarding similarly extravagant overseas board meetings held in the past.According to a comprehensive report by CB
Hanmi Pharmaceutical has received additional approval for the therapeutic use of the anti-cancer drug candidate Belvarafenib, which was technologically transferred to global pharmaceutical company Genentech, a member of the Roche Group (RHO).According to the Ministry of Food and Drug Safety on Jan.
Starting from the second half of this year, South Korean companies will have the option to settle export and import payments in Korean won when engaging in trade transactions with certain countries from the Association of Southeast Asian Nations (ASEAN). This move is expected to allow businesses to
A public tender for a 4.7 trillion won stake in NXC, the holding company of Nexon, has ended empty-handed again.The second tender for 851,968 shares (29.3 percent stake) of NXC failed to find buyers, according to the Online Tender Offer System of Korea Asset Management Corporation (KAMCO) on Dec. 29
A controversy between POSCO and the National Pension Service (NPS), POSCO’s largest shareholder, is showing signs of escalation as the latter questions POSCO Group’s fairness in selecting the its next chairman.According to industry sources on Dec. 29, Kim Tae-hyun, chairman of the NPS, said in a med
Inception Lab,Artificial Intelligence Computer Diagnosis Research Lab in Korea, will receive an innovation award at CES 2024 in Las Vegas, USA, scheduled for January next year.The Consumer Technology Association (CTA), the organizer of CES, evaluates and awards innovation prizes to outstanding produ
LG Electronics is intensifying its foray into the automotive market by enhancing its capabilities in car security platforms. The company plans to expand its market presence by strengthening global marketing and incorporating security technologies into its infotainment systems and telematics componen